A

Aytu BioPharma
D

AYTU

1.36000
USD
-0.03
(-2.16%)
Market Closed
Volume
39
EPS
-3
Div Yield
-
P/E
-1
Market Cap
8,363,142
Related Instruments
    A
    APT
    0.13000
    (2.49%)
    5.35000 USD
    C
    CODX
    0.00330
    (0.45%)
    0.73000 USD
    I
    INO
    -0.01000
    (-0.54%)
    1.83000 USD
    MRNA
    MRNA
    -0.200
    (-0.51%)
    39.360 USD
    O
    OPK
    -0.03000
    (-1.91%)
    1.54000 USD
    More
News

Title: Aytu BioPharma

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidityand a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.